Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.86 USD | +5.62% | +10.37% | -2.80% |
05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
DENALI THERAPEUTICS INC. | Bio Therapeutic Drugs | +5.62% | +10.37% | -2.80% | -34.85% | -3.38% | 2.97B |
Technical Rankings Surperformance
- Stock Market
- Equities
- DNLI Stock
- Charts Denali Therapeutics Inc.
- Comparison Chart